Transition metal compounds as cancer radiosensitizers
The concomitant administration of ionising radiation (IR) in the form of external beam radiotherapy or targeted radionuclide therapy (TRT) alongside radiosensitizing small molecules is a highly successful strategy for the treatment of cancer. The major clinical impact of the radiosensitizing platinu...
Үндсэн зохиолчид: | Gill, M, Vallis, K |
---|---|
Формат: | Journal article |
Хэвлэсэн: |
Royal Society of Chemistry
2018
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
A ruthenium polypyridyl intercalator stalls DNA replication forks, radiosensitizes human cancer cells and is enhanced by Chk1 inhibition
-н: Gill, M, зэрэг
Хэвлэсэн: (2016) -
Radiosensitivity of colorectal cancer to 90Y and the radiobiological implications for radioembolisation therapy
-н: Lee, B, зэрэг
Хэвлэсэн: (2019) -
111In-labelled polymeric nanoparticles incorporating a ruthenium-based radiosensitizer for EGFR-targeted combination therapy in oesophageal cancer cells
-н: Gill, M, зэрэг
Хэвлэсэн: (2018) -
Enhancement of radiosensitization by metal-based nanoparticles in cancer radiation therapy
-н: Xiang-Yu Su, зэрэг
Хэвлэсэн: (2014-06-01) -
Megavoltage radiosensitization of gold nanoparticles on a Glioblastoma Cancer Cell Line using a clinical platform
-н: Kazmi, F, зэрэг
Хэвлэсэн: (2020)